Hospira, Inc. (HSP) - Financial and Strategic SWOT Analysis Review

Summary

Hospira, Inc. (Hospira) is a global specialty pharmaceutical and medication delivery company. The company undertakes the development, manufacturing and marketing of products that help improve the safety and effectiveness and reduce the cost of patient care. It offers hospital products, manufacturing capabilities and technological solutions for hospitals to improve medication and safety management. Hospira also offers one of the broadest portfolios of generic acute care and oncology injectables, integrated infusion therapy, as well as medication management solutions. Its operations are spread across the US, Europe, Latin America and Asia Pacific. Hospira is headquartered in Illinois, the US.

Hospira, Inc. Key Recent Developments

Mar 08, 2013: Hospira Voluntarily Stops All New Sales Of Intravenous Infusion Pumps
Mar 05, 2013: Hospira Announces Completion Of FDA Inspection At Rocky Mount Facility In US
Mar 01, 2013: Hospira Announces Resignation Of Sumant Ramachandra As CSO
Feb 14, 2013: Hospira Receives Form 483 For Manufacturing Concerns
Feb 13, 2013: Hospira Reports Revenue Of $1.1 Billion In Q4 2012

This comprehensive SWOT profile of Hospira, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Hospira, Inc. - Key Facts
Hospira, Inc. - Key Employees
Hospira, Inc. - Key Employee Biographies
Hospira, Inc. - Major Products and Services
Hospira, Inc. - Pharmaceutical Pipeline Products Data
Hospira, Inc., Pipeline Products by Therapy Area
Hospira, Inc., Pipeline Products by Development Phase
Hospira, Inc. - History
Hospira, Inc. - Company Statement
Hospira, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Hospira, Inc. - Key Manufacturing Facilities
Affiliate
Section 2 – Company Analysis
Hospira, Inc. - Business Description
Business Description - Medication Management
Medication Management - Overview
Medication Management - Financials
Medication Management - Technology
Business Description - Other Pharmaceuticals
Other Pharmaceuticals - Overview
Other Pharmaceuticals - Financials
Other Pharmaceuticals - Technology
Business Description - Specialty Injectable Pharmaceuticals
Specialty Injectable Pharmaceuticals - Overview
Specialty Injectable Pharmaceuticals - Financials
Specialty Injectable Pharmaceuticals - Technology
Hospira, Inc. - Corporate Strategy
Hospira, Inc. - SWOT Analysis
SWOT Analysis - Overview
Hospira, Inc. - Strengths
Strength - Broad Product Portfolio
Strength - Strategic Acquisitions
Strength - Strong Product Development Efforts
Strength - Increase in Sales
Hospira, Inc. - Weaknesses
Weakness - Legal Proceedings
Weakness - Product Recalls
Hospira, Inc. - Opportunities
Opportunity - Biotech Focus
Opportunity - Global Drug Delivery Devices Market
Opportunity - Business Initiatives
Hospira, Inc. - Threats
Threat - Competitive Environment
Threat - Cost Containment Pressures
Threat - Overdependence on Third-Party Arrangements
Hospira, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Hospira, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Hospira, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Hospira, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Hospira, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
Hospira, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Hospira, Inc., Recent Developments
Mar 08, 2013: Hospira Voluntarily Stops All New Sales Of Intravenous Infusion Pumps
Mar 05, 2013: Hospira Announces Completion Of FDA Inspection At Rocky Mount Facility In US
Mar 01, 2013: Hospira Announces Resignation Of Sumant Ramachandra As CSO
Feb 14, 2013: Hospira Receives Form 483 For Manufacturing Concerns
Feb 13, 2013: Hospira Reports Revenue Of $1.1 Billion In Q4 2012
Jan 15, 2013: US District Court Rules In Favor Of Ivera Medical Denying Excelsior Medical, Hospira And Catheter Connections’ Motions To Stay Patent Litigation Proceedings
Nov 13, 2012: Hospira Says FDA Prohibits Import Of Symbiq Infusion Pump
Nov 07, 2012: Hospira Reports Revenue Of $994m In Q3 2012
Oct 29, 2012: Hospira Receives Class 1 Recall For Symbiq Infusion System Touchscreen
Aug 22, 2012: Hospira Receives Warning Letter From FDA Over Costa Rica Infusion Device Plant
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Hospira, Inc., Key Facts
Hospira, Inc., Key Employees
Hospira, Inc., Key Employee Biographies
Hospira, Inc., Major Products and Services
Hospira, Inc., Number of Pipeline Products by Therapy Area
Hospira, Inc., Number of Pipeline Products by Development Stage
Hospira, Inc., Pipeline Products By Therapy Area and Development Phase
Hospira, Inc., History
Hospira, Inc., Other Locations
Hospira, Inc., Subsidiaries
Hospira, Inc., Key Manufacturing Facilities
Hospira, Inc., Affiliate
Hospira, Inc., Key Competitors
Hospira, Inc., Ratios based on current share price
Hospira, Inc., Annual Ratios
Hospira, Inc., Interim Ratios
Hospira, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Hospira, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Hospira, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Hospira, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
Hospira, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Hospira, Inc., Pipeline Products by Therapy Area
Hospira, Inc., Pipeline Products by Development Phase
Hospira, Inc., Performance Chart (2008 - 2012)
Hospira, Inc., Ratio Charts
Hospira, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Hospira, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Hospira, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Hospira, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013

Actavis Group hf.
Mylan Inc.
STADA Arzneimittel AG
CareFusion Corporation
B. Braun Melsungen AG
Teva Pharmaceuticals USA, Inc.
Sandoz Inc.
Fresenius Medical Care AG & Co. KGaA
Bedford Laboratories
Baxter International Inc.

Order Online - visit http://www.researchandmarkets.com/reports/1582661

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.